Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-06

Clinical Trial Update: Cod Liver Oil for Covid-19 Prevention Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating cod liver oil for prevention of Covid-19 and respiratory tract infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cod Liver Oil (cod liver oil)

Snippet

Sponsor: Oslo University Hospital | Conditions: Covid-19, Respiratory Tract Infections | Phase 4 | Status: COMPLETED